Company Encyclopedia
View More
name
KINGWORLD
01110.HK
Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series brands. It also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices; and supplies pharmaceuticals, healthcare, general foodstuffs, and medical products. In addition, the company is involved in the distribution and sale of artwork; organization of art exhibitions; distribution and sale of Chinese medicine; and engages in technology transfer and property investment activities.
179.67 B
01110.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care DistributorsIndustry
Industry Ranking10/21
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE0.85%D
    • Profit Margin0.58%C
    • Gross Margin25.21%C
  • Growth ScoreD
    • Revenue YoY-10.50%D
    • Net Profit YoY-82.51%E
    • Total Assets YoY-5.65%D
    • Net Assets YoY-5.90%D
  • Cash ScoreC
    • Cash Flow Margin17311.55%A
    • OCF YoY-10.50%D
  • Operating ScoreB
    • Turnover0.65B
  • Debt ScoreC
    • Gearing Ratio50.08%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Kingworld Medicines Group Ltd. Reports 23% Decline in Revenue and 74.9% Drop in Profit for H1 2025; EPS Falls from 5.20 to -0.94 RMB Cents

    Kingworld Medicines Group Ltd. reported a 23% decline in revenue to RMB 404.85 million and a 74.9% drop in net profit to RMB 11.436 million for H1 2025. The gross profit fell by 25.7% to RMB 102.043 million, with a slight decrease in gross profit margin from 26.1% to 25.2%. The company aims to enhance its market position through nationwide marketing collaborations as part of its strategic initiatives for the second half of 2025.

    Reuters·
    HK
    01110
    0.00%
    Reuters·
    HK
    01110
    0.00%

    KINGWORLD released its interim results, with a loss attributable to shareholders of 5.412 million yuan, turning from profit to loss year-on-year

    According to the Zhitong Finance APP, KINGWORLD released its interim results for the six months ending June 30, 2025, with group revenue of RMB 405 million, a year-on-year decrease of 23%; a loss attributable to shareholders of RMB 5.412 million, turning from profit to loss year-on-year; and a loss per share of 0.94 cents

    Zhitong·
    HK
    01110
    0.00%
    Zhitong·
    HK
    01110
    0.00%

    KINGWORLD issued a profit warning, expecting a loss attributable to owners of approximately HKD 4.5 million in the first half of the year, a year-on-year turnaround from profit to loss

    KINGWORLD expects to incur a loss of approximately 4.5 million yuan in the first half of 2025, turning from profit to loss year-on-year. It is expected that the profit in the first half will decrease by about 70% to 75%, with a profit of 45.6 million yuan in the first half of 2024. The board of directors pointed out that the loss is mainly due to a decrease in gross profit of about 50% to 55% in the Chinese distribution business, due to a slowdown in demand for related products, with some losses offset by an increase in gross profit from Shenzhen Dongdixin Technology Co., Ltd

    Zhitong·
    HK
    01110
    0.00%
    Zhitong·
    HK
    01110
    0.00%

    Kingworld Medicines Sees Decrease In HY Profit By 70%

    Kingworld Medicines Group Ltd :SEES DECREASE IN HY PROFIT BY 70%EXPECTED RESULT DUE TO A SLOWDOWN IN DEMAND OF PHARMACEUTICAL PRODUCTS

    Reuters·
    HK
    01110
    0.00%
    Reuters·
    HK
    01110
    0.00%

    KINGWORLD: Zhang Jianbin resigns as independent non-executive director

    According to the Zhitong Finance APP, KINGWORLD announced that Mr. Zhang Jianbin (Mr. Zhang) has submitted his resignation as an independent non-executive director of the company, chairman of the remuneration committee, member of the audit committee, and member of the nomination committee, effective August 1, 2025, to devote more time to his other personal affairs. Following Mr. Zhang's resignation, Dr. Chu Xiaoping, the company's independent non-executive director, has been appointed as the chairman of the remuneration committee, effective August 1, 2025

    Zhitong·
    HK
    01110
    0.00%
    Zhitong·
    HK
    01110
    0.00%
    © 2025 Longbridge｜Disclaimer